[ET Net News Agency, 21 July 2021] HANSOH PHARMA (03692) fell 5.02% to HK$30.25,
dipping below the 10-D SMA of HK$31.495.
It hits an intra-day low of HK$30.25, and an intra-day high of HK$31.85. The total
shares traded was 1.21 million, with a value of HK$37.69m. The active buy/sell ratio is
55:45, with net buying turnover of HK$3.29m. J.P. MORGAN BRO (HK) accounts for greatest
net responsive buying turnover of HK$3.57m, with volume weighted average price of
HK$30.958. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of
HK$4.09m, with volume weighted average price of HK$31.206. The stock has fallen a combined
5.91% over the past 2 consecutive trading days.
The Hang Seng Index now fell 151 points, or 0.56% to 27,107; the Hang Seng China
Enterprises Index now fell 73 points, or 0.75% to 9,790; the Hang Seng TECH Index now fell
49 points, or 0.68% to 7,287; with an overall turnover of HK$121.55b.
The SSE Composite Index now rose 24 points, or 0.68% to 3,560, with an overall turnover
of RMB468.67b.
The SZSE Component Index now rose 214 points, or 1.43% to 15,225, with an overall
turnover of RMB323.19b.
Basic Information
-------------------------------------------
Nominal 30.250 % Chg -5.02%
High 31.850 Low 30.250
Shares Tr 1.21m Turnover 37.69m
10-D SMA 31.495 %H.V 35.911
20-D SMA 32.677 VWAP 31.046
50-D SMA 32.682 RSI14 36.581
-------------------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 55:45, with net buying
turnover of HK$3.29m, falling a combined 5.91% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HANSOH PHARMA (03692) 30.25 -5.02
SIHUAN PHARM (00460) 2.94 +1.73
TRAD CHI MED (00570) 4.91 -0.61
CMS (00867) 18.64 +1.86
CSPC PHARMA (01093) 10.66 -0.19
SINO BIOPHARM (01177) 6.96 -1.28
3SBIO (01530) 8.10 -0.49
FOSUN PHARMA (02196) 71.20 +4.86
WUXI APPTEC (02359) 188.10 +1.29
PHARMARON (03759) 176.10 +1.67
-------------------------------------------------
(ed)